Cargando…
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
BACKGROUND: Patients with multiple myeloma (MM) remain at an increased risk of infection due to the disease process, as well as the ensuing treatments. METHODS: We performed a systematic review to evaluate the monthly risk of grade III/IV infection, pneumonia, and neutropenia in patients with myelom...
Autores principales: | Balmaceda, Nicole, Aziz, Muhammad, Chandrasekar, Viveksandeep Thoguluva, McClune, Brian, Kambhampati, Suman, Shune, Leyla, Abdallah, Al-Ola, Anwer, Faiz, Majeed, Aneela, Qazilbash, Muzaffar, Ganguly, Siddhartha, McGuirk, Joseph, Mohyuddin, Ghulam Rehman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233183/ https://www.ncbi.nlm.nih.gov/pubmed/34172037 http://dx.doi.org/10.1186/s12885-021-08451-x |
Ejemplares similares
-
Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
por: Gil, Kellen, et al.
Publicado: (2022) -
Hospitalization at the end of life in patients with multiple myeloma
por: Abbasi, Saqib, et al.
Publicado: (2021) -
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
por: Abdallah, Al‐Ola, et al.
Publicado: (2021) -
Financial toxicity in hematological malignancies: a systematic review
por: Ouchveridze, Evguenia, et al.
Publicado: (2022) -
Image enhanced colonoscopy: updates and prospects—a review
por: Shahsavari, Dariush, et al.
Publicado: (2023)